HCPLive staff

The approval, which was was supported by data from a 56-week trial involving 223 obese individuals 12-17 years old, recommended the capsules be used in conjunction with a reduced-calorie diet and increased physical activity.

The most recent protests to police brutality, and the ensuing violence across cities and towns, sparked response from most national medical institutions—who for decades have sought to address disparities in care.

The Abbott-developed test platform is already used as a molecular point-of-care device for influenza A and B, Strep A, and respiratory syncytial virus.

Younger patients display increased susceptibility to H1N1 relative to H3N2, according to study findings.

The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.

Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.

The results of the largest study of its kind to date indicate that new antipsychotic medications-including quetiapine, olanzapine, and risperidone-do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.

Fluticasone furoate/vilanterol (Breo Ellipta/GlaxoSmithKline and Theravance Inc) approved for the once-daily treatment of asthma in patients aged 18 years and older.

In contrast to recent studies linking patients who reside in higher elevations with increased rates of depression and suicide, a new study suggests that the prevalence of attention-deficit hyperactivity disorder appears to decrease as altitude increases.

Albert Einstein College of Medicine researchers have developed a new vaccine type that shows promise to possibly become the first ever for preventing genital herpes.

Study shows that the majority of people who report "hearing voices" actually hear multiple distinct voices, and that many patients also report physical effects from their condition.

Being just a few blocks from such entertainment icons as Broadway and the Metropolitan Opera House the Voice Center at Voice Center at the NYU Langone Medical Center doctors treat everyone from stars to understudies to the salesmen on 5th Avenue.

Patients with exocrine pancreatic insufficiency treated with pancreatin for up to one year experienced improvements in gastrointestinal symptoms and reduction in the severity of their recurrent pain.

Once a diagnosis of Craniosynostosis is made there is still much more work to be done including determining what kind of the condition exists. The form of the defect then determines what kind of operation is needed to remedy the condition.

Onextron (clindamycin phosphate and benzoyl peroxide), 1.2%/3.75%, has been approved for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.

Research and real-world experience has shown interventions such as constraint therapy, botulinum toxin therapy, and interactive computer play to be effective in children and adolescents with cerebral palsy.

Results from a study of herpes zoster incidence following periods of acute stress in a large cohort of patients suggest the conventional wisdom on this subject may be wrong.

Stendra (avanafil) is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.

Movantik (naloxegol), an oral peripherally acting mu-opioid receptor antagonist, has been approved by the FDA for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) is a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.

A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.

The brains of hyperglycemic patients with Type 1 diabetes produce elevated levels of the neurotransmitter glutamate, which may increase their risk of depression.

Inhaler-delivered drug is a once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.

Sodium picosulfate, a commonly prescribed medication for bowel prep prior to colonoscopy, is associated with increased risk of hyponatremia in older adults compared to polyethylene glycol.

Recently released guidelines seek to provide clarity to the management of hyponatremia by outlining an evidence-based, patient-centered approach to diagnosis and treatment.